duaklir genuair
covis pharma europe b.v. - aclidinium бромид, формотерола фумарата дигидрат - Белодробна болест, хронична обструктивна болест - Лекарства за обструктивна заболявания на дихателните пътища, - duaklir genuair е посочено като поддръжка бронходилататор лечение за облекчаване на симптомите при възрастни пациенти с хронична обструктивна белодробна болест (ХОББ).
brimonidine tartrate/timolol teva 2mg/ml + 5mg/ml eye drops
2mg/ml + 5mg/ml eye drops
brimonidine tartrate teva 0,2 % eye drops, solution
0,2 % eye drops, solution
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - Захарен диабет тип 2 - Лекарства, използвани при диабет - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
ramipril+bisoprolol fumarate elc 2,5 mg/1,25 mg capsules, hard
2,5 mg/1,25 mg capsules, hard
ramipril+bisoprolol fumarate elc 2,5 mg/2,5 mg capsules, hard
2,5 mg/2,5 mg capsules, hard
ramipril+bisoprolol fumarate elc 5 mg/2,5 mg capsules, hard
5 mg/2,5 mg capsules, hard
ramipril+bisoprolol fumarate elc 5 mg/5 mg capsules, hard
5 mg/5 mg capsules, hard
ramipril+bisoprolol fumarate elc 10 mg/5 mg capsules, hard
10 mg/5 mg capsules, hard
ramipril+bisoprolol fumarate elc 10 mg/10 mg capsules, hard
10 mg/10 mg capsules, hard